Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2003
10/14/2003US6633820 System for assessing metal deterioration on maritime vessels
10/14/2003US6633818 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations
10/14/2003US6633662 Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images
10/14/2003US6633370 Quantum dots, semiconductor nanocrystals and semiconductor particles used as fluorescent coding elements
10/14/2003US6633369 Method for determining the volume of individual red blood cells or other particles that are suspended in liquids. The sample is disposed into an optical cuvette suitable for microscopic analysis. An absorbing dye is added that does not
10/14/2003US6633368 Method for determining the volume of single red blood cells
10/14/2003US6632933 Use of azetidinone compounds
10/14/2003US6632929 Avidin derivatives and uses thereof
10/14/2003US6632926 Amino acids inserted in hypervariable region; heavy chain variable domain of an antibody that binds vascular endothelial growth factor
10/14/2003US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632844 Methods and compositions for preserving glucose level in blood specimens
10/14/2003US6632794 Insulin-like growth factor agonist molecules
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632682 One-step immunoassay for the determination of antigen-specific antibodies of one of the immunoglobulin classes A, M, D, or E, and an agent suitable for this purpose
10/14/2003US6632681 Reagent delivery device and method of use
10/14/2003US6632678 Method for performing activated clotting time test with reduced sensitivity to the presence of aprotinin and for assessing aprotinin sensitivity
10/14/2003US6632676 Isotonic diluent reagent aqueous solution of sodium and/or potassium sulfate; blood cell lysing and hemoglobin conversion reagent; automatic hematology analyzers
10/14/2003US6632675 Packaged in laminated foil containers; oxidation resistance, shelf life; hermetic sealing
10/14/2003US6632674 Method of testing gas detection instruments and associated apparatus
10/14/2003US6632664 Foreign gene inserted into an untranslated region in the genome
10/14/2003US6632634 Decay accelerating factor (DAF) and nucleic acid encoding it
10/14/2003US6632629 Enzyme assay for labeling, separation, detection, and determining the concentration of amino acids, peptides, and proteins in biological samples
10/14/2003US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy
10/14/2003US6632625 Ob (obesity gene); receptors may be used in various assays, such as a transactivation assay to identify novel ligands
10/14/2003US6632624 Use immunoassay for precise measurement of levels of intact chromogranin A and the levels of major fragments found in circulating blood
10/14/2003US6632623 Use in improving process of differentiating patients with prostate cancer (PCa) from patients with benign prostatic hyperplasia (BPH) or healthy male subjects without PCa
10/14/2003US6632622 Assay for evaluation of cellular response to allergens
10/14/2003US6632618 Morphogenic protein-specific cell surface receptors and uses therefor
10/14/2003US6632615 Method for isolating a target biological material, capture phase, detecting phase and reagent containing them
10/14/2003US6632613 Compositions and kits for fluorescence polarization assay of large molecules
10/14/2003US6632612 Synthesis of chemical tags
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632603 Non-captive substrate liquid phase immunoassay
10/14/2003US6632601 Immunoassays for anti-HCV antibodies
10/14/2003US6632599 Detection and determination of solid phase-associated factors
10/14/2003US6632598 Paraffin-solubilizing organic solvents; tissue samples; histological analysis; aqueous wash solutons; surfactants; use for dewaxing wax-embedded biologial specimens prior to histochemical analysis
10/14/2003US6632534 Measuring the moisture content in soils
10/14/2003US6632526 A population of polymeric microspheres dyed with two or more fluorescent squarylium dyes; multiplexed analysis of a plurality of analytes in a single sample
10/14/2003US6632434 Leptospiral major outer membrane protein, LipL 32
10/14/2003US6632432 Plasma from donors immunized with Staphylococcal epidermidis vaccine comprising antigens in TCA (trichloroacetic acid) extractions
10/14/2003US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification
10/14/2003US6632426 G-CSF analog compositions and methods
10/14/2003US6632402 Oxygen monitoring apparatus
10/14/2003US6632353 Rapid sample collection in supercritical fluid chromatography
10/14/2003US6632349 Device comprising electrochemical cell having sensing chamber, electrodes, aperture for admitting sample into chamber, red blood cell lysing agent, and reagent within chamber capable of being reduced by hemoglobin to generate electrical signal
10/14/2003US6632180 Controlling blood pressure, by measuring blood renin concentration, then administering hypotensive agents such as diuretics, adrenergic blocking agents and/or mixtures
10/14/2003US6631650 Thief sampling probe
10/14/2003CA2288376C Syndecan interacting proteins and the use thereof
10/14/2003CA2107894C Crosstalk inhibitors and their uses
10/14/2003CA2081657C Denatured vehicular proteins to improve enzyme linked immunosorbent assays
10/10/2003WO2003087326A2 Automated protein crystallization imaging
10/10/2003CA2444484A1 Automated protein cyrstallization imaging
10/09/2003WO2003083905A2 Novel integrated circuit chip for bioassays_____________________
10/09/2003WO2003083660A1 Adaptive behavioral intrusion detection systems and methods
10/09/2003WO2003083609A2 Systems, methods and computer program products for determining parameters for chemical synthesis
10/09/2003WO2003083490A2 Method for predicting antiphospholid syndrome
10/09/2003WO2003083489A1 System for performing blood coagulation assays and measuring blood clotting times
10/09/2003WO2003083488A2 Method for identifying stat affecting agents
10/09/2003WO2003083487A2 Method of screening of compounds inducing a prolonged qt intervalon the electrocardiogram
10/09/2003WO2003083486A1 Method of judging cardiotoxicity of anthracycline-type anticancer chemical therapeutic by detecting human h-fabp and reagent therefor
10/09/2003WO2003083485A2 Protein for use in hypoxia related conditions
10/09/2003WO2003083484A2 Fluorescence-based mucus assay
10/09/2003WO2003083483A1 Inhibitors of caspase-3-mediated cleavage of essential ventricular myosin light chain
10/09/2003WO2003083482A1 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases
10/09/2003WO2003083481A2 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies
10/09/2003WO2003083480A1 Methods for manufacturing nanoparticle structures using hydrophobic or charged surfaces
10/09/2003WO2003083479A1 Blood processing method, blood processing device, method of measuring hemoglobins and device for measuring hemoglobins
10/09/2003WO2003083478A1 Biochip sensor surface carrying polyethylene glycolated nanoparticles
10/09/2003WO2003083477A2 Active solid support and method for surface immobilization of combinatorial compounds or libraries
10/09/2003WO2003083476A1 Detection of dna-binding proteins
10/09/2003WO2003083474A1 Test piece for analyzing substance with biological origin, process for producing the same and method of examining test piece for substance with biological origin
10/09/2003WO2003083473A1 Substrates for hybridization and method of using the same
10/09/2003WO2003083472A1 Method of judging risk of peiodontal disease
10/09/2003WO2003083471A1 Method and apparatus for defining the tearing strength of paper material or the like
10/09/2003WO2003083470A1 Method of analyzing water environment, method of deciding water environment measures, method of managing water environment and systems therefor
10/09/2003WO2003083469A2 Integrated sample testing meter
10/09/2003WO2003083465A1 NOx MEASUREMENT DEVICE, NOx SENSOR SELF-DIAGNOSIS DEVICE, AND SELF-DIAGNOSIS METHOD THEREOF
10/09/2003WO2003083463A2 Apparatus and method for electrochemical detection and control of inorganic scale
10/09/2003WO2003083443A2 Lipid mediated screening of drug candidates for identification of active compounds
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083441A2 Identification of apoptotic peptides and methods of use thereof
10/09/2003WO2003083440A2 Methods and compositions for detection and quantitation of nucleic acid analytes
10/09/2003WO2003083438A2 Methods and systems for molecular modeling
10/09/2003WO2003083436A2 Fibrinogen binding moieties
10/09/2003WO2003083435A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification
10/09/2003WO2003083431A2 Pressure activated calibration system for chemical sensors
10/09/2003WO2003083141A1 Interpreting cytological specimens via molecular histological signatures
10/09/2003WO2003083139A1 Method of examining allergic disease
10/09/2003WO2003083138A2 Methods of evaluating dna-based links
10/09/2003WO2003083136A1 Method and kit for detecting membrane protein-protein interactions
10/09/2003WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2)
10/09/2003WO2003083134A1 Sensor for the quantitative and qualitative determination of (bio)organic oligomers and polymers, corresponding analysis method, and method for the production of said sensor
10/09/2003WO2003083133A1 Method of detecting mild impaired glucose tolerance or insulin hyposecretion
10/09/2003WO2003083130A2 Detection of malaria parasites by mass spectrometry
10/09/2003WO2003083124A2 Peptide epitopes common to antigens of the same multigene family
10/09/2003WO2003083116A1 Emthod of screening transporter inhibitor
10/09/2003WO2003083115A1 Abc transporter-associated gene abcc13
10/09/2003WO2003083113A2 Growth regulating proteins
10/09/2003WO2003083112A1 Cell population provided with identification codes and method of screening cell population
1 ... 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 ... 3937